New approaches to the assessment of vaccine herd protection in clinical trials.
about
Key issues for estimating the impact and cost-effectiveness of seasonal influenza vaccination strategiesEconomic Evaluations of Childhood Influenza VaccinationDissecting the indirect effects caused by vaccines into the basic elementsImproving immunization approaches to cholera.Evaluation of vaccines against enteric infections: a clinical and public health research agenda for developing countriesImpact of vaccine herd-protection effects in cost-effectiveness analyses of childhood vaccinations. A quantitative comparative analysis.Development of a cholera vaccination policy on the Island of Hispaniola, 2010-2013Measuring indirect effects of rotavirus vaccine in low income countriesRole of pneumococcal vaccination in prevention of pneumococcal disease among adults in SingaporeIntroducing new vaccines in developing countries.Spillover effects on health outcomes in low- and middle-income countries: a systematic review.Herd protection by a bivalent killed whole-cell oral cholera vaccine in the slums of Kolkata, India.Substantial Decline in Vaccine-Type Human Papillomavirus (HPV) Among Vaccinated Young Women During the First 8 Years After HPV Vaccine Introduction in a Community.Ratio of anogenital warts between different anatomical sites in homosexual and heterosexual individuals in Australia, 2002-2013: implications for susceptibility of different anatomical sites to genital warts.Spillover effects in epidemiology: parameters, study designs and methodological considerations.A Recipe for inferference: Start with Causal Inference. Add Interference. Mix Well with R.
P2860
Q22305437-3B600F68-6EB1-4C4C-AEDD-C80E1CE5B4F1Q22305810-1CFAAB1E-121D-4DF9-A218-EFE224DAFF72Q26799527-25589922-2032-4308-8FFD-CB3FD5D6B4E4Q30151668-8D120816-4352-4DD6-A3C7-3DE35CE2396BQ35137102-3BBADF6F-BBAB-4C56-A7B7-22125839D840Q36294177-FEF8BB7C-EBB2-4F42-977E-C4332A68A8A3Q37225767-6E8E7B6E-CFF2-43E3-81A6-F9DAC9C7B535Q37306509-96E5280B-0DFD-45C3-ADD5-EB56DB6CF3B4Q37685565-CDD99AC7-3470-48FB-9E4C-E1A5A86B4E76Q38160253-9BDD43C4-3540-434A-A2C8-2C2858EC2531Q38690184-FD5AFF65-3C2C-4962-98BD-D681096C7727Q40088781-61A8A910-DECA-4510-865E-9E1DC697112BQ40509494-13581E0E-3583-446E-9996-021A9A7C9F56Q41360720-FF54A75A-1473-4ED1-96E7-DB7CC29F1A5AQ47626140-BAA723CF-B24F-4FA7-AB61-503B91F77378Q50073595-C7319599-ED88-4BD1-B4D2-F820E92949A4
P2860
New approaches to the assessment of vaccine herd protection in clinical trials.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
New approaches to the assessment of vaccine herd protection in clinical trials.
@en
New approaches to the assessment of vaccine herd protection in clinical trials.
@nl
type
label
New approaches to the assessment of vaccine herd protection in clinical trials.
@en
New approaches to the assessment of vaccine herd protection in clinical trials.
@nl
prefLabel
New approaches to the assessment of vaccine herd protection in clinical trials.
@en
New approaches to the assessment of vaccine herd protection in clinical trials.
@nl
P2093
P1476
New approaches to the assessment of vaccine herd protection in clinical trials.
@en
P2093
John Clemens
Mohammad Ali
Sunheang Shin
P304
P356
10.1016/S1473-3099(10)70318-2
P577
2011-06-01T00:00:00Z